173 related articles for article (PubMed ID: 27259379)
1. Imaging for the Pretreatment Staging of Small cell Lung Cancer: A Systematic Review.
Mitchell MD; Aggarwal C; Tsou AY; Torigian DA; Treadwell JR
Acad Radiol; 2016 Aug; 23(8):1047-56. PubMed ID: 27259379
[TBL] [Abstract][Full Text] [Related]
2. Small Cell Lung Cancer Staging: Prospective Comparison of Conventional Staging Tests, FDG PET/CT, Whole-Body MRI, and Coregistered FDG PET/MRI.
Ohno Y; Yoshikawa T; Takenaka D; Koyama H; Aoyagi K; Yui M; Oshima Y; Hamabuchi N; Tanaka Y; Shigemura C; Oota S; Nomura M; Murayama K; Inui Y; Kikukawa K; Toyama H
AJR Am J Roentgenol; 2022 May; 218(5):899-908. PubMed ID: 34877872
[No Abstract] [Full Text] [Related]
3. Performance Comparison Between
Kishida Y; Seki S; Yoshikawa T; Itoh T; Maniwa Y; Nishimura Y; Ohno Y
AJR Am J Roentgenol; 2018 Jul; 211(1):185-192. PubMed ID: 29667886
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients.
Wu Y; Li P; Zhang H; Shi Y; Wu H; Zhang J; Qian Y; Li C; Yang J
Int J Cancer; 2013 Jan; 132(2):E37-47. PubMed ID: 22890912
[TBL] [Abstract][Full Text] [Related]
5. 18F-FDG PET or PET/CT for detecting extensive disease in small-cell lung cancer: a systematic review and meta-analysis.
Lu YY; Chen JH; Liang JA; Chu S; Lin WY; Kao CH
Nucl Med Commun; 2014 Jul; 35(7):697-703. PubMed ID: 24694775
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic performance of [18F] FDG PET-CT compared to bone scintigraphy for the detection of bone metastases in lung cancer patients.
Rodrigues M; Stark H; Rendl G; Rettenbacher L; Datz L; Studnicka M; Pirich C
Q J Nucl Med Mol Imaging; 2016 Mar; 60(1):62-8. PubMed ID: 26844431
[TBL] [Abstract][Full Text] [Related]
7. Resected Pure Small Cell Lung Carcinomas and Combined Small Cell Lung Carcinomas: Histopathology Features, Imaging Features, and Prognoses.
Woo JH; Kim MY; Lee KS; Jeong DY; Chung MJ; Han J; Shim YM
AJR Am J Roentgenol; 2019 Apr; 212(4):773-781. PubMed ID: 30673331
[TBL] [Abstract][Full Text] [Related]
8. Comparison of diagnostic ability between (99m)Tc-MDP bone scan and (18)F-FDG PET/CT for bone metastasis in patients with small cell lung cancer.
Lee JW; Lee SM; Lee HS; Kim YH; Bae WK
Ann Nucl Med; 2012 Oct; 26(8):627-33. PubMed ID: 22729551
[TBL] [Abstract][Full Text] [Related]
9. [Small-cell lung carcinoma: CT imaging features].
Ridene I; Ben Miled-M'rad K; Zidi A; Hantous-Zannad S; Baccouche I
J Radiol; 2011 Jan; 92(1):3-7. PubMed ID: 21352720
[TBL] [Abstract][Full Text] [Related]
10. The role of integrated 18F-FDG PET-CT as a staging tool for limited-stage small cell lung cancer: a retrospective study.
Sohn BS; Lee DH; Kim EK; Yoon DH; Kim HO; Ryu JS; Kim SW; Suh C
Onkologie; 2012; 35(7-8):432-8. PubMed ID: 22846975
[TBL] [Abstract][Full Text] [Related]
11. PET and PET-CT of lung cancer.
Steinert HC
Methods Mol Biol; 2011; 727():33-51. PubMed ID: 21331927
[TBL] [Abstract][Full Text] [Related]
12. Small cell lung carcinoma: staging, imaging, and treatment considerations.
Carter BW; Glisson BS; Truong MT; Erasmus JJ
Radiographics; 2014 Oct; 34(6):1707-21. PubMed ID: 25310425
[TBL] [Abstract][Full Text] [Related]
13. Staging and imaging of small cell lung cancer.
Kalemkerian GP
Cancer Imaging; 2012 Jan; 11(1):253-8. PubMed ID: 22245990
[TBL] [Abstract][Full Text] [Related]
14. Positron emission tomography in limited-stage small-cell lung cancer: a prospective study.
Bradley JD; Dehdashti F; Mintun MA; Govindan R; Trinkaus K; Siegel BA
J Clin Oncol; 2004 Aug; 22(16):3248-54. PubMed ID: 15310768
[TBL] [Abstract][Full Text] [Related]
15. Effect of Accurate Staging Using Positron Emission Tomography on the Outcomes of Prophylactic Cranial Irradiation in Patients With Limited Stage Small-Cell Lung Cancer.
Choi M; Lee Y; Moon SH; Han JY; Kim HT; Lee JS
Clin Lung Cancer; 2017 Jan; 18(1):77-84. PubMed ID: 27461775
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of outcome prediction and disease extension by quantitative 2-deoxy-2-[18F] fluoro-D-glucose with positron emission tomography in patients with small cell lung cancer.
Arslan N; Tuncel M; Kuzhan O; Alagoz E; Budakoglu B; Ozet A; Ozguven MA
Ann Nucl Med; 2011 Jul; 25(6):406-13. PubMed ID: 21409347
[TBL] [Abstract][Full Text] [Related]
17. Fluorine-18 deoxyglucose positron emission tomography, magnetic resonance imaging and bone scintigraphy for the diagnosis of bone metastases in patients with lung cancer: which one is the best?--a meta-analysis.
Liu T; Xu JY; Xu W; Bai YR; Yan WL; Yang HL
Clin Oncol (R Coll Radiol); 2011 Jun; 23(5):350-8. PubMed ID: 21094027
[TBL] [Abstract][Full Text] [Related]
18. Impact of [18F]FDG-PET on the primary staging of small-cell lung cancer.
Brink I; Schumacher T; Mix M; Ruhland S; Stoelben E; Digel W; Henke M; Ghanem N; Moser E; Nitzsche EU
Eur J Nucl Med Mol Imaging; 2004 Dec; 31(12):1614-20. PubMed ID: 15258700
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
